Source: Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Janelle Pugashetti, Julia Graham, Noelle Boctor, Cesar Mendez, Elena Foster, Maya Juarez, Richart Harper, Brian Morrissey, Michael Kadoch, Justin M. Oldham. Weight loss as a predictor of mortality in patients with interstitial lung disease. Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018

Member's Comments

No comment yet.

Related content which might interest you: Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Associations between comorbidities and survival in patients with interstitial lung diseases Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy Source: Eur Respir J 2006; 27: 689-696 Year: 2006 Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients. Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Interstitial lung abnormalities in smokers are associated with increased mortality Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Body mass index predicts survival in patients with pulmonary hypertension in chronic lung disease Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 BNP can be an all-cause mortality predictor in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Predictors of quality of life in patients with interstitial lung disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease Source: International Congress 2016 – Sarcoidosis Year: 2016 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016